Host: Rabbit
Target Protein: Bone Sialoprotein 2
Immunogen Range: 21-120/317
Clonality: Polyclonal
Isotype: IgG
Entrez Gene: 3381
Swiss Prot: P21815
Source: KLH conjugated synthetic peptide derived from human Bone sialoprotein II
Purification: Purified by Protein A.
Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Background:
Size: 100ul
Concentration: 1ug/ul
Applications:
WB(1:300-5000)
ELISA(1:500-1000)
IHC-P(1:200-400)
IHC-F(1:100-500)
IF(IHC-P)(1:50-200)
IF(IHC-F)(1:50-200)
IF(ICC)(1:50-200)
Predicted Molecular Weight: 34
Cross Reactive Species: Human
Predicted Cross Reactive Species:
Mouse
Rat
For research use only. Not intended for diagnostic or therapeutic use.
- Yang, Zhenhua, et al. "Cessation of epithelial Bmp signaling switches the differentiation of crown epithelia to the root lineage in a β-catenin-dependent manner." Molecular and Cellular Biology (2013): MCB-00456.Read more>>
- Potter AS, Potter SS (2015) Molecular Anatomy of Palate Development. PLoS ONE 10(7): e0132662. doi:10.1371Read more>>
- Shi R et al. Analysis of the characteristics and expression profiles of coding and noncoding RNAs of human dental pulp stem cells in hypoxic conditions.Stem Cell Res Ther. 2019 Mar 12;10(1):89.Read more>>
- Jilong Zou. et al. Resveratrol Benefits the Lineage Commitment of BMSCs into Osteoblasts via MiR\320c by Targeting Runx2. 2021 Jan 22Read more>>
- Zheng, Han. et al. miR-140-3p enhanced the osteo/odontogenic differentiation of DPSCs via inhibiting KMT5B under hypoxia condition. Int J Oral Sci. 2021 Dec;13(1):1-1Read more>>
- Xing Yifeng. et al. Osteogenic effects of rapamycin on bone marrow mesenchymal stem cells via inducing autophagy. J ORTHOP SURG RES. 2023 Dec;18(1):1-13Read more>>
Lane 1: Mouse Bone tissue lysates; Lane 2: Rat Bone tissue lysates probed with Bone Sialoprotein 2 Polyclonal Antibody, Unconjugated (bs-2668R) at 1:500 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.